FDA.reportPublic FDA data

Cellzyme Ampoule

Manufacturer
PHARMACAL-INTERNATIONAL. CO., LTD | GreenCos Co., Ltd
Effective date
2017-09-15
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:11:58

Label at a glance#

ProductCellzyme Ampoule
Active ingredientGLYCERIN, EUCALYPTUS OIL, ALLANTOIN
Label structure8 sections

Dosage and administration

Apply smoothly on the entire face in the morning and night

Label contents#

Full prescribing information#

Actvie Ingrdients

OTC - ACTIVE INGREDIENT SECTION

GLYCERIN (Skin protectant/7%)

EUCALYPTUS OIL (Skin protectant /0.1%)

ALLANTOIN (Skin protectant/0.03%)

Inactives

INACTIVE INGREDIENT SECTION

WATER,BUTYLENE GLYCOL, NIACINAMIDE, 1,2-HEXANEDIOL, GLYCOSYL TREHALOSE, HYDROGENATED STARCH, HYDROLYSATE, SODIUM HYALURONATE, GLYCERYL POLYACRYLATE, ALBUMEN EXTRACT, HYDROLYZED COLLAGEN, ALOE BARBADENSIS LEAF EXTRACT, BACILLUS/HOUTTUYNIA CORDATA EXTRACT FERMENT FILTRATE, PANAX GINSENG ROOT EXTRACT, SCUTELLARIA BAICALENSIS ROOT EXTRACT, MORUS ALBA BARK EXTRACT, CNIDIUM OFFICINALE ROOT EXTRACT, GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT, SOLANUM LYCOPERSICUM, (TOMATO) CALLUS CULTURE EXTRACT, NELUMBO NUCIFERA FLOWER EXTRACT, PORTULACA OLERACEA EXTRACT, ADENOSINE, HYDROXYETHYLCELLULOSE, CARBOMER, TROMETHAMINE, PEG-60 HYDROGENATED CASTOR OIL, DISODIUM EDTA, FRAGRANCE

Purpose 

OTC - PURPOSE SECTION

Skin Protectant

Indication and Usage

INDICATIONS & USAGE SECTION

Protect the skin. Helps wrinkle improvement and skin whitening.

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

Apply smoothly on the entire face in the morning and night

Warnings

WARNINGS SECTION

If following symptoms occur, stop use and consult a doctor: red spots, swelling, itching, irritation, or symptoms on applied skin under direct sunlight. Do not use on scarred skin, or if you have dermatitis or eczema. Keep away from direct sunlight or heat. Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children 

Product Labels

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage descriptionimage descriptionimage description

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
24765-11024765-110-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 26 matching rows.

Name, UNII, Kind table
NameUNIIKind
GLYCERINPDC6A3C0OXACTIB
EUCALYPTUS OIL2R04ONI662ACTIB
ALLANTOIN344S277G0ZACTIB
WATER059QF0KO0RIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
NIACINAMIDE25X51I8RD4IACT
1,2-HEXANEDIOLTR046Y3K1GIACT
BEMISIOSE76B4LOB2YCIACT
HYDROGENATED STARCH HYDROLYSATE27F77DSJ5VIACT
HYALURONATE SODIUMYSE9PPT4THIACT
EGG WHITE3E0I92Z2GRIACT
ALOE VERA LEAFZY81Z83H0XIACT
HOUTTUYNIA CORDATA FLOWERING TOPRH041UUZ22IACT
ASIAN GINSENGCUQ3A77YXIIACT
MORUS ALBA BARK7O71A48NDPIACT
CNIDIUM OFFICINALE ROOT8S3OZD358JIACT
GLYCYRRHIZA GLABRA2788Z9758HIACT
TOMATOZ4KHF2C175IACT
NELUMBO NUCIFERA FLOWER61W322NLDVIACT
PURSLANEM6S840WXG5IACT
ADENOSINEK72T3FS567IACT
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)R33S7TK2EPIACT
CARBOXYPOLYMETHYLENE0A5MM307FCIACT
TROMETHAMINE023C2WHX2VIACT
PEG-60 HYDROGENATED CASTOR OIL02NG325BQGIACT
EDETATE DISODIUM ANHYDROUS8NLQ36F6MMIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c3568f58-9cb9-a52a-e053-2a95a90a66aa29d335cb-33bf-441d-aa75-5c7eb2b5344c2021-05-27WarningsExact identifier
spl set id: 29d335cb-33bf-441d-aa75-5c7eb2b5344c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.